Here's a countdown of the top 13 health scares of 2013!
The Advisory Committee on Immunization Practices has recommended that all boys and girls receive the HPV vaccine before they become sexually active. Yet the vaccination rates continue to be low. According to the 2011 National Immunization Survey among teens, only 35 percent of girls ages 13 to 17
We were very disappointed in Katie Couric s segment yesterday on her daytime talk show, Katie, discussing the controversy over the vaccine
A new study in the Journal of Adolescent Health provides some sobering statistics about the use of the vaccines that can prevent cancers caused by the human papilloma virus (HPV). Although primarily developed to prevent HPV infection (and thus, cervical cancer) in women, its use has been expanded to boys, since the vaccine also protects against anal and oropharyngeal cancers (the tongue, tonsils,soft palate, and pharynx a part of the throat).
Human papillomavirus (HPV) continues to be the most common sexually transmitted infection in the United States. Although in most cases, the infection is successfully eradicated by our normal immune
A new report about a big jump in the incidence of HPV-related oral cancers over the past few decades is both sobering and unexpected. Farzan Siddiqui, M.D., Ph.D., who is the director of the Head & Neck Radiation Therapy Program at the Henry Ford Hospital in Detroit, presented some eye-opening data at the 55th Annual Meeting of the American Society for Radiation Oncology in Atlanta.
Teen vaccination rates are all over the board, according to the CDC. In order to assess vaccination rates,
The human papillomavirus (HPV) is the most common sexually transmitted disease, and also the cause of cervical cancer. While vaccination has proven to be an extremely effective
The human papillomavirus (HPV) vaccine, which protects women against cervical cancer, also appears to likely to protect them against
According to a survey published this month in the American Journal of Preventive Medicine, less than one third of obstetrician-gynecologists give eligible patients the HPV vaccine and only half adhere to the guidelines published in 2009. These guidelines recommend vaccinating women ages 11 26 years, a recommendation that has been in effect since 2006. In 2009, the American Congress of Obstetricians and Gynecologists (ACOG) added additional guidelines recommending biannual Pap tests for women between the ages of 21 and 29.